Healthtech Startups

Amotio develops a guided bone cement removal system with patient-specific surgical planning and precision instrumentation for orthopaedic revision surgery, targeting arthroplasty and revision surgeons who work with cemented joint implants. The medical device company, based in the Netherlands and Wales, is preparing for US commercial launch in the revision arthroplasty market.

1 investor

Amoy Diagnostics develops molecular diagnostic test kits for cancer detection, including PCR, IHC, FISH, and next-generation sequencing products that detect gene mutations such as PIK3CA, KRAS, NRAS, BRAF, and IDH1, as well as microsatellite instability. Its products serve clinical and oncology diagnostics and include related nucleic acid extraction reagents and instruments.

1 investor

Amperos automates and manages insurance claim recovery for healthcare providers, reducing denials and processing backlogs through a combination of automation and expert oversight. The platform helps revenue cycle teams resolve claims with improved consistency and visibility.

1 investor

Amphastar Pharmaceuticals manufactures and distributes generic and branded pharmaceutical products, including injectable medications, inhalation aerosols, and emergency treatments for medical professionals and patients in the United States.

1 investor

Amplicore Pharma develops an injectable pharmaceutical formulation targeting musculoskeletal disorders, particularly osteoarthritis, designed to slow cartilage degeneration and reduce symptoms as an alternative to joint replacement surgery.

1 investor

Amplifai develops an AI-powered platform (TFscan) that detects diabetic foot complications in real time to support clinical decision-making and prevent amputations. The system integrates with hospital and clinic infrastructure to provide risk scores and analytics for patient care teams.

1 investor

Amplifi Vascular develops the Amplifi Vein Dilation System, a wearable external blood pump with inflow and outflow catheters that uses proprietary hemodynamic technology to enlarge veins before arteriovenous fistula (AVF) creation. The device is intended to increase patient eligibility for AVF surgery and improve vascular access outcomes for hemodialysis patients.

1 investor

Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.

1 investor

Amplo Biotechnology develops adeno-associated virus (AAV) gene therapies for genetic diseases of the neuromuscular junction, targeting rare and ultra-rare patient populations such as those with Congenital Myasthenic Syndromes. Its work focuses on delivering proteins like Dok-7 and Collagen Q that are essential to neuromuscular junction function.

1 investor

AMPS provides cost management solutions for self-insured employers, focusing on member experience and expense optimization.

1 investor

AMR Bio develops XF-73, a first-in-class topical antimicrobial candidate in Phase 3 trials designed to prevent post-surgical infections, with the lead program targeting pre-operative decolonization in surgical settings. The company also advances dermal formulations for severe wound and skin infections.

1 investor

AMSlab is a biotechnology company focused on research, development, and innovation in analytical methods and quality control. The company develops solutions for detecting and identifying compounds across healthcare, food safety, marine toxins, and related biotech applications.

1 investor

AMT Medical develops the Elana Anastomotic System, a medical device using a clip and laser catheter to create the distal anastomosis connecting a graft to the coronary artery in coronary bypass (CABG) surgery. The device targets cardiac surgeons and care teams and supports open, off-pump, and minimally invasive procedures including MIDCAB and robotic-assisted TECAB techniques.

1 investor

Amulyte develops a portable monitoring and activity tracking system designed to detect falls and help seniors maintain independent living at home without requiring a fixed base station.

1 investor

Amygdala Neurosciences is a biopharmaceutical company developing oral medications to treat alcohol and substance use disorders by targeting the ALDH2 enzyme. The company addresses unmet clinical needs in addiction treatment through novel pharmacotherapies.

1 investor

A drug discovery company focused on medicinal chemistry and preclinical research across multiple therapeutic areas.

1 investor

Everlife Analisa Resources is a laboratory and scientific solutions distributor founded in 1999, providing instruments, chemistries, consumables, software, and technical services to life sciences, analytical testing, and diagnostic markets across Asia. The company serves scientists, research institutions, biotechnology firms, and industries including pharmaceuticals, food, and chemicals.

1 investor

RxList is an online medical resource providing detailed pharmaceutical information on brand and generic drugs, written and reviewed by pharmacists and physicians. The platform serves consumers seeking reliable drug information and pill identification tools.

1 investor

Analytical Wizards provides AI/ML and advanced analytics tools and services for the healthcare and life sciences industry, covering patient and claims analytics, market sizing, clinical trial acceleration, healthcare provider influence mapping, and omnichannel commercial optimization. It serves pharmaceutical and healthcare clients seeking insights into patients, providers, and healthcare organizations using real-world data.

1 investor

AnalytiChem manufactures and distributes laboratory chemicals and reference materials, including certified reference materials, elemental and organic standards, prepared culture media, high-purity acids, and instrument consumables. It serves scientists and laboratories across the mining, petroleum, environmental, food, and life sciences industries.

1 investor

Anamnèse offers a modular e-health software platform for digitizing care pathways, combining shared calendars, medical records, patient evaluation via 250+ scales/scores, telemedicine, care-pathway management (eParcours), PROM/PREM collection, and clinical research tools. It serves healthcare and prevention actors across France — practitioners, CPTS, MSP, clinics, companies, schools and mutual insurers — from city medicine to hospital and medico-social settings.

1 investor

The Smart Headgear Sensor is a wearable impact sensor device designed for combat athletes (boxers and MMA fighters) to track and measure training performance and head impact data during fights and sparring sessions.

1 investor

Anatomic Studios designs and produces custom prosthetic covers that emphasize personal expression and aesthetic choice alongside function. The company works with prosthetics clinics and users globally to create tailored cosmetic solutions for upper and lower limb prosthetics.

1 investor

Anatomiz3D develops patient-specific surgical planning solutions and tissue engineering products using 3D printing and bioprinting technologies for the healthcare industry. The company aims to improve surgical outcomes and eventually reduce organ transplant dependency through customized medical interventions.

1 investor